Hauptinhalt

APSIN

Efficacy and safety of Adjuvant Peptide receptor radionuclide therapy after curative surgery of locoregional limited Small Intestine Neuroendocrine neoplasia

• Studiendauer: 60 Monate (5 Jahre)
• Patienten und Patientinnen: 160 (80 pro Gruppe)